Headquarters: Abingdon, Oxfordshire, United Kingdom
Industry: Gene Therapy
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Investors Number: 7
Investment Stage: N/A
Investor Type: Company
Funding Status: N/A
Number Of Exists: Venture - Series Unknown
Technology: Cancer
Last Funding Type: Venture - Series Unknown
Founded Date: 2006
Total Funding: $102.5M